RAYMOND JAMES & ASSOCIATES - ALDEYRA THERAPEUTICS INC ownership

ALDEYRA THERAPEUTICS INC's ticker is ALDX and the CUSIP is 01438T106. A total of 120 filers reported holding ALDEYRA THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.40 and the average weighting 0.1%.

Quarter-by-quarter ownership
RAYMOND JAMES & ASSOCIATES ownership history of ALDEYRA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$341,021
-21.6%
51,051
-1.5%
0.00%
Q2 2023$434,703
+63.1%
51,812
+93.0%
0.00%
Q1 2023$266,541
+49.2%
26,842
+4.6%
0.00%
Q4 2022$178,656
+24.1%
25,669
-5.1%
0.00%
Q3 2022$144,000
+15.2%
27,049
-13.4%
0.00%
Q2 2022$125,000
+6.8%
31,226
+18.7%
0.00%
Q1 2022$117,000
+34.5%
26,306
+21.2%
0.00%
Q4 2021$87,000
-78.4%
21,697
-52.7%
0.00%
Q3 2021$403,000
-23.2%
45,847
-1.1%
0.00%
Q2 2021$525,000
+98.1%
46,342
+107.8%
0.00%
Q1 2021$265,000
+69.9%
22,300
-2.2%
0.00%
Q4 2020$156,000
-7.7%
22,7980.0%0.00%
Q3 2020$169,000
+83.7%
22,798
+3.2%
0.00%
Q2 2020$92,000
+50.8%
22,100
-10.2%
0.00%
Q1 2020$61,000
-53.4%
24,600
+8.8%
0.00%
Q4 2019$131,000
+12.0%
22,600
+1.8%
0.00%
Q3 2019$117,000
+13.6%
22,200
+29.8%
0.00%
Q2 2019$103,00017,1000.00%
Other shareholders
ALDEYRA THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
SPHERA FUNDS MANAGEMENT LTD. 1,009,131$7,568,0001.15%
Knoll Capital Management, LLC 124,096$931,0000.96%
683 Capital Management, LLC 1,000,000$7,500,0000.66%
Perceptive Advisors 3,085,458$23,141,0000.65%
MANGROVE PARTNERS IM, LLC 324,019$2,430,0000.16%
Stanley-Laman Group, Ltd. 64,029$480,0000.11%
WOODSTOCK CORP 67,759$508,0000.10%
Hikari Power Ltd 107,858$809,0000.10%
ARDSLEY ADVISORY PARTNERS LP 45,000$336,0000.05%
ADAGE CAPITAL PARTNERS GP, L.L.C. 750,000$5,625,0000.01%
View complete list of ALDEYRA THERAPEUTICS INC shareholders